Daniel Grizelj Vertex Pharmaceuticals (NASDAQ:VRTX) is trading around +6.5% premarket on Tuesday after it reported positive results from a Phase…
Read More »Daniel Grizelj Vertex Pharmaceuticals (NASDAQ:VRTX) is trading around +6.5% premarket on Tuesday after it reported positive results from a Phase…
Read More »